-
Loading metrics
Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus
-
Aminata Sy ,
Contributed equally to this work with: Aminata Sy, Leanne McCabe, Sarah L. Pett
Roles Data curation, Writing – original draft, Writing – review & editing
* E-mail: a.sy@imperial.ac.uk
Affiliation MRC Clinical Trials Unit, University College London, London, United Kingdom
⨯ - Leanne McCabe ,
- Emma Hudson,
- Azim M. Ansari,
- Vincent Pedergnana,
- Shang-Kuan Lin,
- S. Santana,
- Marzia Fiorino,
- Aftab Ala,
- Ben Stone,
- M. Smith,
- Mark Nelson,
- Stephen T. Barclay,
- Stuart McPherson,
- Stephen D. Ryder,
- Jane Collier,
- Eleanor Barnes,
- Ann Sarah Walker,
- Sarah L. Pett ,
- Graham Cooke,
- [ ... ],
- on behalf of the STOP-HCV-1 trial team
- [ view all ]
- [ view less ]
https://orcid.org/0000-0001-9630-6538
Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus
- Aminata Sy,
- Leanne McCabe,
- Emma Hudson,
- Azim M. Ansari,
- Vincent Pedergnana,
- Shang-Kuan Lin,
- S. Santana,
- Marzia Fiorino,
- Aftab Ala,
- Ben Stone
x
- Published: January 23, 2023
- https://doi.org/10.1371/journal.pone.0280551